semaglutide epilepsy and the risk of adult-onset in type 2 diabetes Approach to epilepsy : Internal

Noguera, V

and participation on advisory boards for Boehringer Ingelheim, GlaxoSmithKline, Madrigal, Novo Nordisk and Sagimet

This makes them a dual-action therapy targeting both metabolic and inflammatory pathways

This consumer-friendly approach has its advantages - the process is fast, intuitive, and low-friction - and its potential downsides, as some patients and healthcare commentators have noted that the simplified experience may make the prescribing process feel somewhat transactional

This includes a significant decrease in appetite, a reduction in caloric intake of approximately 30%, and a slowing of gastric emptying, which promotes an earlier and more prolonged feeling of fullness, sometimes accompanied by nausea, even after small meals